Related Experiment Video
Updated: Dec 24, 2025
Separation of Immune Cell Subpopulations in Peripheral Blood Samples from Children with Infectious Mononucleosis
Published on: September 7, 2022
A Biomarker-Based Approach to Infectious Disease in the Pediatric Emergency Department
1College of Natural Sciences, University of Texas-Austin, University Station, Austin, TX.
Insights
Novel biomarkers for pediatric infectious diseases can improve emergency department (ED) care. Rapid bedside diagnostic assays using these biomarkers will enhance timely diagnosis and treatment for better patient outcomes.
Area of Science:
- Pediatric Emergency Medicine
- Infectious Diseases Diagnostics
- Biomarker Discovery
Background:
- Pediatric emergency medicine requires rapid diagnostics for effective disease management.
- Current diagnostic methods for pediatric infectious diseases in the emergency department (ED) can be improved.
- There is a critical need for novel, disease-specific biomarkers to enhance pediatric care.
Purpose of the Study:
- To review novel biomarkers for diagnosing common pediatric infectious diseases in the ED.
- To provide a rationale for using molecular or biomarker-based approaches in emergency diagnostics.
- To emphasize the importance of diagnostic rapidity for timely and quality emergency care.
Main Methods:
- Review of existing literature on novel biomarkers.
- Focus on cytokines, chemokines, and nitric oxide-based metabolites.
- Discussion of disease pathophysiology to support biomarker utility.
Main Results:
- Identification of diverse novel biomarkers, including cytokines and chemokines.
- Emphasis on the potential for rapid, bedside point-of-care assays.
- Rationale for biomarker application based on disease mechanisms and diagnostic speed.
Conclusions:
- Novel biomarkers offer significant potential for improving pediatric infectious disease diagnostics in the ED.
- Rapid bedside biomarker assays can enhance diagnostic accuracy and prognostic capabilities.
- The integration of these biomarkers promises to improve the timeliness and quality of emergency pediatric care.
Abstract:
In modern pediatric emergency medicine, biomarker-based assays that enable quick bedside diagnostics and subsequent disease management can be valuable. There is a growing need for novel, disease-specific biomarkers that can improve the outcome of pediatric infectious diseases commonly encountered in the emergency department (ED). Viral respiratory infections, central nervous system infections, sepsis, and septic shock are acute disease states frequently encountered in the ED. In this review, we describe a host of novel biomarkers, including a diverse set of cytokines, chemokines, and nitric oxide-based metabolites. Based on disease pathophysiology, a rationale is provided for a molecular- or biomarker-based approach in the ED. Throughout this review, emphasis is placed on diagnostic rapidity because this relates directly to timeliness and quality of care in a busy ED. Once the biomarkers become more clinically available, in a rapid ED setting as bedside point-of-care assays, quality of care will be enhanced, not only by means of diagnostics but also in prognosticating severity of illness.
